Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Plans to reduce lab animal use welcomed by RSPCA
The plan could lead to developments of more humane alternatives.
The government says it is committed to replacing lab animals with non-animal alternatives.

The Royal Society for the Prevention of Cruelty to Animals (RSPCA) has welcomed the government’s commitment to a plan to reduce and replace the use of lab animals in science.

The charity says that the government’s plan, due to be published this summer, will make a difference to three million animals used in experiments each year.

The plan was announced Andrew Griffith MP, minister for science, research and innovation, during a debate in Westminster Hall last week. Mr Griffith said the plans would ‘accelerate the development, validation and uptake of technologies and methods to reduce reliance on the use of animals in science’.

As part of the plans, the government would double investments for initiatives which could lead to a reduced use of lab animals, raising investments from £10 million per year to £20 million per year in 2024/2025.

The RSPCA says that the government’s actions could play a key role in developing more humane alternatives to using animals in experiments.

Animals, such as fish, mice and rats, are commonly used in research and testing for a variety of purposes. These animals may be used to understand how human and animal bodies function, to develop and test new medicines, and to assess the safety of chemicals.

However, the RSPCA says this has raised ethical, scientific and animal welfare issues. It suggests that a number of humane alternatives, many of which are already successfully used, could be used instead of lab animals.

Among the alternatives that could be used are isolated cells and tissues, simple organisms and mathematical models.

Chris Sherwood, RSPCA’s chief executive, said: “We warmly welcome this commitment to reducing and replacing the use of animals in science, which could make a huge difference for the three million lab animals currently used in the UK each year.

“This is a positive development and comes after many years of the RSPCA leading calls for bolder action to accelerate the transition to non-animal technologies and approaches in science. The announcement of a new plan due this summer is a promising start and we look forward to seeing more detail as we all strive to create a better world for every animal.”

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.